stock

Eli Lilly & Co. (LLY)

0
September 3rd, 2020

Share

Stay up to date

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. Its products include Forteo, Adrica, BAQSIMI, Basaglar and Glucagn. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.

Financial Statements

Key Info

  • Industry: Pharmaceuticals: Major
  • Sector: Health Technology
  • CEO Name: David A. Ricks

Key Statistics

  • Stock Price: $149.55
  • Dividend Yield: 1.9%
  • Market Capitalization: $143,040,088,500
  • Shares Outstanding: 956,470,000
  • Number of Employees: 33,625
  • Trailing 12-Month EPS: $6.17
  • Trailing 12-Month DPS: $2.77
  • Payout Ratio: 44.9%

Important Dates

  • Next Earnings Date: 2020-10-27
  • Next Ex-Dividend Date: 2020-08-13

Price Trends

  • Current Stock Price: $149.55
  • 52-week high: $170.75
  • 52-week low: $101.36
  • 200-day moving average: $144.6
  • 50-day moving average: $157.41

Performance

  • 1-Month Price Return: -2.2%
  • 3-Month Price Return: -2.0%
  • 6-Month Price Return: 14.8%
  • 1-Year Price Return: 31.2%
  • 2-Year Price Return: 83.1%
  • 5-Year Price Return: 90.0%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

September 3rd, 2020